• 14C custom radiolabelling, specialising in 14C GMP API, for metabolism, environmental fate and human ADME studies.
  • Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.
  • Unique peptidyl prolyl isomerase (PPIase) screening platform including binding and functional assays.
  • Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Drug Discovery

Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions.

Read more

Medicinal Chemistry
Assay Development and Screening
Target Class and Disease Expertise

Radiolabelling

14C custom radiolabelling for metabolism, environmental fate and specialising in 14C GMP API for human ADME studies.

Read more

14C Custom Synthesis
14C GMP Radiolabelled API for Clinical Trials
GLP Analytics

Chemistry & Analytics

Structural elucidation and impurity profiling; synthesis and GLP characterisation of process impurity, degradation products and metabolites.

Read more

Custom Synthesis
Crop Science Expertise
GLP anaysis including GLP NMR

News

30 June 2015
Selcia Ltd has received renewal under the French Research Tax Credit scheme for the years 2015,...
26 June 2015
Selcia is proud to join the Safety Alliance, a network of selected high-quality CROs across Europe.

Upcoming Events

9 August 2015 to 12 August 2015
Vicky Steadman is presenting at Drug Discovery Re-invented in Ascot, UK
13 September 2015 to 16 September 2015
Vicky Steadman will be presenting at the 18th SCI/RSC Medicinal Chemistry Symposium in Cambridge.

Selcia Tweets